| Peer-Reviewed

Prevalence and Risk Factors of Dyslipidemia Among Adults: A Community Based Study in Addis Ababa, Ethiopia

Received: 11 December 2021     Accepted: 10 January 2022     Published: 18 January 2022
Views:       Downloads:
Abstract

Dyslipidemia is the leading population-level risk factor for ischemic heart disease in Africa. There were inadequate data regarding the prevalence and associated factors of dyslipidemia. So, this survey aimed to identify the prevalence and associated factors of dyslipidemia among participants aged 18 years and above in Addis Ababa city, capital of Ethiopia. This cross-sectional community-based survey was conducted from June to October 2018; in the Ethiopian capital of Addis Ababa. Participants 18 years of age and older were selected by using a multi-stage probability sampling method. The data was gathered through an in-person interview. The WHO phased-in approach was used for data collection. In addition, respondents' height, weight, waist, hip, blood pressure, and laboratory investigations were performed in keeping with standard procedures. We used multiple logistic regressions to analyze the data and, Odds ratios with 95% confidence intervals were also calculated to assess the factors that had an association. Four hundred fifty 77.3 % (95% CI: 73.9-80.7) of study respondents had a minimum of one kind of lipid abnormalities. Hypertriglyceridemia and low HDL-cholesterol were the more common dyslipidemia 41.4% (95% CI: 37.4–45.4) and 41.1% (95% CI: 37.1–45.1), respectively. Among all respondents who had at least one type of dyslipidemia 433 (96.2%) were, newly diagnosed during the survey. In multivariable logistic regression, analysis being male, age≥30 years, raised blood glucose, sitting per day for more than 3 hours, and being hypertensive were the factors associated with hypertriglyceridemia; being female, obese and raised blood glucose were the factors significantly related with low HDL-C; being female, age ≥30 years and hypertensive were the factors associated with hypercholesterolemia. Low HDL-Cholesterol and hypertriglyceridemia were the more common dyslipidemia. With a large proportion unaware of their status, intervention measures have to be taken targeting the modifiable risk factors and screening programs for adults with risk factors.

Published in American Journal of Nursing Science (Volume 11, Issue 1)
DOI 10.11648/j.ajns.20221101.13
Page(s) 20-29
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

Dyslipidemia, Hypertriglyceridemia, Hypercholesterolemia, Low HDL-C, Prevalence, Risk Factors

References
[1] World Health Organization. Global status report on noncommunicable diseases 2014: World Health Organization; 2014.
[2] Alwan Ala. Global status report on noncommunicable diseases 2010: World Health Organization; 2011.
[3] World Health Organization. Noncommunicable diseases country profiles 2018. 2018.
[4] François Mach. et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European heart journal. 2020; 41 (1): 111-88.
[5] Angelantonio Di. Gao E. & Pennells P. Emerging risk factors collaboration. Lipid-related markers and CVD prediction. JAMA. 2012; 307: 2499-506.
[6] Wahed Wafaa YY Abdel. El-Khashab Khalid & Hassan Safaa Khamis. Prevalence of Dyslipidemia among Healthy University Students: Fayoum Governorate, Egypt. Epidemiology, Biostatistics and Public Health. 2016; 13 (2).
[7] Allan Sniderman. RETRACTED: The principles & practice of LDL lowering therapy. Elsevier; 2015.
[8] Neil J Stone. et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2014; 63 (25 Part B): 2889-934.
[9] Madhan Shanmugasundaram. Steven J Rough & Joseph S Alpert. Dyslipidemia in the elderly: should it be treated? Clinical cardiology. 2010; 33 (1): 4-9.
[10] Eyup Avci. Ahmet Dolapoglu & Didar Elif Akgun. Role of cholesterol as a risk factor in cardiovascular diseases. Cholesterol-Good, Bad and the Heart. 2018.
[11] Krisela Steyn. et al. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation. 2005; 112 (23): 3554-61.
[12] Raul Vinueza. et al. Dyslipidemia in seven Latin American cities: CARMELA study. Preventive medicine. 2010; 50 (3): 106-11.
[13] Sampson Opoku. et al. Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP). BMC public health. 2019; 19 (1): 1500.
[14] Li Cai. Lei Zhang. Aiping Liu. Shuping Li & Peiyu Wang. Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China. Journal of atherosclerosis and thrombosis. 2011: 1110310428.
[15] Gershim Asiki. et al. Prevalence of dyslipidaemia and associated risk factors in a rural population in South-Western Uganda: a community based survey. PloS one. 2015; 10 (5): e0126166.
[16] Okpara Ihunanya Chinyere & Adediran Olufemi Sola. Dyslipidemia and its relationship with different anthropometric measures in Nigerian adults. IOSR J Dent Med Sci. 2013; 9: 7-12.
[17] Awoke Misganaw. Damen Hai l e Mari am & Tekebash Araya. The Double Mortality Burden Among Adults in Addis Ababa, Ethiopia, 2006-2009. Centers for Disease Control and Prevention - Preventing Chronic Disease. 2012; 9, 2012: 11_0142.
[18] Eric Bruckert. Epidemiology of low HDL-cholesterol: results of studies and surveys. European heart journal supplements. 2006; 8 (suppl_F): F17-F22.
[19] Gebreyes YF. et al. Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: Evidences from the National NCDs STEPS Survey, 2015. PLOS ONE. May 9, 2018 13 (5): e0194819.
[20] Ethiopia Public Health Institute. ETHIOPIA STEPS REPORT ON RISK FACTORS FOR CHRONIC NON-COMMUNICABLE DISEASES AND PREVALENCE OF SELECTED NCDs. December 2016.
[21] Tesfaye F Byass P & Wall S. Population based prevalence of high blood pressure among adults in Addis Ababa: uncovering a silent epidemic. BMC Cardiovascular Disorders. 2009; 9 (39).
[22] Tran A. et al. Prevalence of metabolic syndrome among working adults in Ethiopia. International journal of hypertension. 2011; 2011.
[23] Ambachew Henock. Shimelis Techalew & Lemma Kinfe. Dyslipidemia among diabetic patients in Southern Ethiopia: Cross-sectional study. Journal of Diabetes and Endocrinology. 2015; 6 (4): 19-24.
[24] Federal Democratic Republic of Ethiopia Addis Ababa City Administration. Ethiopia Transportation System Improvement Project (TRANSIP) Social Impact Assessment (SIA). January, 2016.
[25] Asemu MM, Yalew AW, Kabeta ND, Mekonnen D. Prevalence and risk factors of hypertension among adults: A community based study in Addis Ababa, Ethiopia. PloS one. 2021; 16 (4): e0248934.
[26] Federal Democratic Republic of Ethiopia Central Statistical Agency. Population Projection of Ethiopia for All Regions At Wereda Level from 2014 – 2017. Addis Ababa: August 2013.
[27] World Health Organization. The WHO STEPwise approach to chronic disease risk factor surveillance. Geneva: World Health Organization. 2005.
[28] Chobanian AV et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003.
[29] World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. 2006.
[30] NCEP ATPIII. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486-97.
[31] Alberti K George MM. Zimmet Paul & Shaw Jonathan. The metabolic syndrome—a new worldwide definition. The Lancet. 2005; 366 (9491): 1059-62.
[32] Joshi SR. ea. Prevalence of Dyslipidemia in Urban and Rural India: The ICMR–INDIAB Study. PLOS ONE. May 9, 2014; 9 (5): e96808.
[33] Reiger Sheridan. et al. Awareness, treatment, and control of dyslipidemia in rural South Africa: The HAALSI (Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa) study. PloS one. 2017; 12 (10): e0187347.
[34] Mengesha AB. Epidemiology of Preventable Risk Factors for Non-communicable Diseases among Adult Population in Tigray, Northern Ethiopia [Dissertation]: University of South Africa; May, 2015.
[35] Ebrahimi H, Emamian MH, Hashemi H, Fotouhi A. Dyslipidemia and its risk factors among urban middle-aged Iranians: A population-based study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2016; 10 (3): 149-56.
[36] Carrillo-Larco RM, Benites-Moya CJ, Anza-Ramirez C, Albitres-Flores L, Sánchez-Velazco D, Pacheco-Barrios N, et al. A systematic review of population-based studies on lipid profiles in Latin America and the Caribbean. eLife. 2020; 9: e57980.
[37] Okaka Enajite I & Eiya Bibiana O. Prevalence and pattern of dyslipidemia in a rural community in Southern Nigeria. African Journal of Medical and Health Sciences. 2013; 12 (2): 82.
[38] Erem Cihangir. Hacihasanoglu Arif. Deger Orhan. Kocak Mustafa & Topbas Murat. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study. Endocrine. 2008; 34 (1-3): 36-51.
[39] Poehlman Eric T. et al. Physiological predictors of increasing total and central adiposity in aging men and women. Archives of internal medicine. 1995; 155 (22): 2443-8.
[40] Streja Dan & Streja Elani. Management of dyslipidemia in the elderly. Endotext [Internet]: MDText. com, Inc.; 2017.
[41] Baharudin. GVHTTYMHPS. Differential impact of aging and gender on lipid and lipoprotein profiles in a cohort of healthy Chinese Singaporeans. Asian journal of andrology. 2007; 9 (6): 787-94.
[42] Qi Li. Ding Xianbin. Tang Wenge. Li Qin. Mao Deqiang & Wang Yulin. Prevalence and risk factors associated with dyslipidemia in Chongqing, China. International journal of environmental research and public health. 2015; 12 (10): 13455-65.
[43] Anil B. Rani S. Revikumar KG. Shafeeque M & Unnikrishnan UG. Assessment of correlation in gender and age with lipoprotein levels in hyperlipidemia patients. Asian J Pharm Clin Res. 2016; 9: 197-9.
[44] Wang Shuang. Xu Liang. Jonas Jost B. You Qi Sheng. Wang Ya Xing & Yang Hua. Prevalence and associated factors of dyslipidemia in the adult Chinese population. PloS one. 2011; 6 (3): e17326.
[45] Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, et al. A potential decline in life expectancy in the United States in the 21st century. New England Journal of Medicine. 2005; 352 (11): 1138-45.
[46] Ge Pengfei. et al. The High Prevalence of Low HDL-Cholesterol Levels and Dyslipidemia in Rural Populations in Northwestern China. PLOS ONE December 7, 2015 10 (12).
[47] Al-Raddadi R, Bahijri SM, Jambi HA, Ferns G, Tuomilehto J. The prevalence of obesity and overweight, associated demographic and lifestyle factors, and health status in the adult population of Jeddah, Saudi Arabia. Therapeutic Advances in Chronic Disease. 2019; 10: 2040622319878997.
[48] Haslam D, James W. Obesity Lancet, 366 (9492), 1197–1209. Health Physics Society (2009) Online, availableat: www hps org/publicinformation/ate/q535 html. 2005.
[49] Grundy SM, Arai H, Barter P, Bersot TP, Betteridge DJ, Carmena R, et al. An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia-full report. Journal of Clinical Lipidology. 2014; 8 (1): 29-60.
[50] Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001; 104 (22): 2746-53.
[51] Tripathy JP, Thakur J, Jeet G, Chawla S, Jain S, Pal A, et al. Burden and risk factors of dyslipidemia-results from a STEPS survey in Punjab India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2017; 11: S21-S7.
Cite This Article
  • APA Style

    Meseret Molla Asemu, Alemayehu Worku Yalew, Negussie Deyessa, Desalewu Mekonnen Kassie. (2022). Prevalence and Risk Factors of Dyslipidemia Among Adults: A Community Based Study in Addis Ababa, Ethiopia. American Journal of Nursing Science, 11(1), 20-29. https://doi.org/10.11648/j.ajns.20221101.13

    Copy | Download

    ACS Style

    Meseret Molla Asemu; Alemayehu Worku Yalew; Negussie Deyessa; Desalewu Mekonnen Kassie. Prevalence and Risk Factors of Dyslipidemia Among Adults: A Community Based Study in Addis Ababa, Ethiopia. Am. J. Nurs. Sci. 2022, 11(1), 20-29. doi: 10.11648/j.ajns.20221101.13

    Copy | Download

    AMA Style

    Meseret Molla Asemu, Alemayehu Worku Yalew, Negussie Deyessa, Desalewu Mekonnen Kassie. Prevalence and Risk Factors of Dyslipidemia Among Adults: A Community Based Study in Addis Ababa, Ethiopia. Am J Nurs Sci. 2022;11(1):20-29. doi: 10.11648/j.ajns.20221101.13

    Copy | Download

  • @article{10.11648/j.ajns.20221101.13,
      author = {Meseret Molla Asemu and Alemayehu Worku Yalew and Negussie Deyessa and Desalewu Mekonnen Kassie},
      title = {Prevalence and Risk Factors of Dyslipidemia Among Adults: A Community Based Study in Addis Ababa, Ethiopia},
      journal = {American Journal of Nursing Science},
      volume = {11},
      number = {1},
      pages = {20-29},
      doi = {10.11648/j.ajns.20221101.13},
      url = {https://doi.org/10.11648/j.ajns.20221101.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajns.20221101.13},
      abstract = {Dyslipidemia is the leading population-level risk factor for ischemic heart disease in Africa. There were inadequate data regarding the prevalence and associated factors of dyslipidemia. So, this survey aimed to identify the prevalence and associated factors of dyslipidemia among participants aged 18 years and above in Addis Ababa city, capital of Ethiopia. This cross-sectional community-based survey was conducted from June to October 2018; in the Ethiopian capital of Addis Ababa. Participants 18 years of age and older were selected by using a multi-stage probability sampling method. The data was gathered through an in-person interview. The WHO phased-in approach was used for data collection. In addition, respondents' height, weight, waist, hip, blood pressure, and laboratory investigations were performed in keeping with standard procedures. We used multiple logistic regressions to analyze the data and, Odds ratios with 95% confidence intervals were also calculated to assess the factors that had an association. Four hundred fifty 77.3 % (95% CI: 73.9-80.7) of study respondents had a minimum of one kind of lipid abnormalities. Hypertriglyceridemia and low HDL-cholesterol were the more common dyslipidemia 41.4% (95% CI: 37.4–45.4) and 41.1% (95% CI: 37.1–45.1), respectively. Among all respondents who had at least one type of dyslipidemia 433 (96.2%) were, newly diagnosed during the survey. In multivariable logistic regression, analysis being male, age≥30 years, raised blood glucose, sitting per day for more than 3 hours, and being hypertensive were the factors associated with hypertriglyceridemia; being female, obese and raised blood glucose were the factors significantly related with low HDL-C; being female, age ≥30 years and hypertensive were the factors associated with hypercholesterolemia. Low HDL-Cholesterol and hypertriglyceridemia were the more common dyslipidemia. With a large proportion unaware of their status, intervention measures have to be taken targeting the modifiable risk factors and screening programs for adults with risk factors.},
     year = {2022}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Prevalence and Risk Factors of Dyslipidemia Among Adults: A Community Based Study in Addis Ababa, Ethiopia
    AU  - Meseret Molla Asemu
    AU  - Alemayehu Worku Yalew
    AU  - Negussie Deyessa
    AU  - Desalewu Mekonnen Kassie
    Y1  - 2022/01/18
    PY  - 2022
    N1  - https://doi.org/10.11648/j.ajns.20221101.13
    DO  - 10.11648/j.ajns.20221101.13
    T2  - American Journal of Nursing Science
    JF  - American Journal of Nursing Science
    JO  - American Journal of Nursing Science
    SP  - 20
    EP  - 29
    PB  - Science Publishing Group
    SN  - 2328-5753
    UR  - https://doi.org/10.11648/j.ajns.20221101.13
    AB  - Dyslipidemia is the leading population-level risk factor for ischemic heart disease in Africa. There were inadequate data regarding the prevalence and associated factors of dyslipidemia. So, this survey aimed to identify the prevalence and associated factors of dyslipidemia among participants aged 18 years and above in Addis Ababa city, capital of Ethiopia. This cross-sectional community-based survey was conducted from June to October 2018; in the Ethiopian capital of Addis Ababa. Participants 18 years of age and older were selected by using a multi-stage probability sampling method. The data was gathered through an in-person interview. The WHO phased-in approach was used for data collection. In addition, respondents' height, weight, waist, hip, blood pressure, and laboratory investigations were performed in keeping with standard procedures. We used multiple logistic regressions to analyze the data and, Odds ratios with 95% confidence intervals were also calculated to assess the factors that had an association. Four hundred fifty 77.3 % (95% CI: 73.9-80.7) of study respondents had a minimum of one kind of lipid abnormalities. Hypertriglyceridemia and low HDL-cholesterol were the more common dyslipidemia 41.4% (95% CI: 37.4–45.4) and 41.1% (95% CI: 37.1–45.1), respectively. Among all respondents who had at least one type of dyslipidemia 433 (96.2%) were, newly diagnosed during the survey. In multivariable logistic regression, analysis being male, age≥30 years, raised blood glucose, sitting per day for more than 3 hours, and being hypertensive were the factors associated with hypertriglyceridemia; being female, obese and raised blood glucose were the factors significantly related with low HDL-C; being female, age ≥30 years and hypertensive were the factors associated with hypercholesterolemia. Low HDL-Cholesterol and hypertriglyceridemia were the more common dyslipidemia. With a large proportion unaware of their status, intervention measures have to be taken targeting the modifiable risk factors and screening programs for adults with risk factors.
    VL  - 11
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia

  • School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia

  • School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia

  • College of Health Science, Addis Ababa University, Addis Ababa, Ethiopia

  • Sections